Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
La ribonucleoprotein domain family, member 7 pseudogene (ENSG00000275419) is a genomic locus classified as a pseudogene. Pseudogenes are gene copies that have lost their protein-coding ability due to disabling mutations such as frameshifts, stop codons, or promoter loss, and do not encode functional proteins[2][6][8]. This particular pseudogene is related by sequence to the LARP7 gene, which encodes a transcriptional regulator involved in snRNA processing and negative regulation of transcription elongation[1]. However, the pseudogene itself has no established function, is not expressed as a protein, and has no direct medical or therapeutic role. Typically, pseudogenes are not included among drug targets or biomarkers in biomedical research unless a specific RNA-level function is demonstrated, which is not established for this locus[2][4][6].\n\n**Key interpretation:**\nThis entry is for a **pseudogene**, not an active protein-coding gene or therapeutic target. Any potential reference to LARP7 activity or function should instead refer to the **protein-coding gene** (e.g., LARP7/ENSG00000174720)[1], not the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on La ribonucleoprotein domain family, member 7 pseudogene.